Randox in the Racing World - Sensitive Screening Solutions
News Mar 23, 2009
Randox supply a comprehensive range of diagnostic solutions for the detection of prohibited substances in international racing.
Randox have developed a new novel screening technology known as Biochip Array Technology. This latest revolution from Randox can be used for testing samples from Equine and Canine racing samples. Randox Biochip Array Technology is a screening system which enables simultaneous testing of multiple analytes using one single sample. It is a technology based on ELISA principles - but rather than binding antibodies to a microtitre plate the analytes are bound to a 9mm x 9mm Biochip on different X Y co-ordinates. Randox offer a wide portfolio of drugs of abuse, growth promoters, synthetic steroids and their metabolites.
Randox also have a comprehensive range of ELISA kits which includes Beta-agonists, Boldenone, Corticosteroids, 19-Nortestosterone/Trenbolone, Ractopamine, Stanozolol, Trenbolone, Phenylbutazone and Zeranol, with the release of a Flunixin and Ketamine ELISA coming soon. All kits offer excellent limits of detection, a wide range of sample matrices, small sample volume and outstanding cross reactivity.
To complement our range of screening tests Randox have developed a range of immunoaffinity columns for sample purification prior to sample analysis by screening or confirmatory technology such as GC/MS, LC/MS. Randox immunoaffinity columns are efficient, whilst also being cost-effective and convenient. Available columns have long shelf lives and come with equilibration and storage buffers. Available columns include Clenbuterol/ß-agonists, Corticosteroids, Trenbolone and 19-Nortestosterone, Stilbene, Zeranol and our new multi-analyte Growth Promoter column.
High-Resolution Mass Spectrometry Reveals Pathways in Photosystem II Water SystemNews
Researchers have capitalised on the incredible accuracy, speed and sensitivity of new mass spectrometry instruments to provide the first comprehensive study of how an ancient photosynthetic organism uses and regulates water to create energy.READ MORE
Source of a Potent Greenhouse Gas IdentifiedNews
A study of a Lake Erie wetland suggests that scientists have vastly underestimated the number of places methane-producing microbes can survive—and, as a result, today’s global climate models may be misjudging the amount of methane being released into the atmosphere.READ MORE
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE